Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.960
-0.030 (-0.75%)
At close: Mar 27, 2026

HKG:2185 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-87.94-175.89-204.24-361.45
Depreciation & Amortization
8.0521.2720.8613.23
Other Amortization
0.120.09--
Loss (Gain) From Sale of Assets
1.4730.510-
Loss (Gain) From Sale of Investments
32.17-0.47--
Loss (Gain) on Equity Investments
0.991.631.43-
Stock-Based Compensation
-47.63140.48318.72
Other Operating Activities
-7.34-19.5-50.63-42.05
Change in Inventory
-14.35-3.98--
Change in Accounts Payable
0.1--0.01-
Change in Unearned Revenue
-0.6-0.92-0.981.37
Change in Other Net Operating Assets
-52.2250.6-47.53-18.3
Operating Cash Flow
-119.55-49.03-140.62-88.47
Capital Expenditures
-47.14-17.72-30.04-34.27
Sale of Property, Plant & Equipment
-0.11--
Sale (Purchase) of Intangibles
--0.26--0.43
Investment in Securities
--15-74.66-
Other Investing Activities
1.1144.010.97
Investing Cash Flow
-46.03-28.86-100.69-33.73
Long-Term Debt Repaid
-2.12-5.26-3.59-4.29
Total Debt Repaid
-2.12-5.26-3.59-4.29
Net Debt Issued (Repaid)
-2.12-5.26-3.59-4.29
Issuance of Common Stock
---395.25
Repurchase of Common Stock
---29.44-
Other Financing Activities
-0.32-0.56-2.15-7.27
Financing Cash Flow
-2.44-5.82-35.18383.68
Foreign Exchange Rate Adjustments
0.971.8219.27-6.61
Net Cash Flow
-167.05-81.88-257.21254.86
Free Cash Flow
-166.69-66.74-170.65-122.75
Free Cash Flow Per Share
-0.69-0.27-0.70-0.56
Levered Free Cash Flow
-134.87-3.8-77.4126.76
Unlevered Free Cash Flow
-134.83-3.44-76.8127.19
Change in Working Capital
-67.0745.71-48.52-16.93
Source: S&P Global Market Intelligence. Standard template. Financial Sources.